Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07613931 · ClinicalTrials.gov registry record · Early Phase 1
Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
A Early Phase 1 study, sponsored by Tactile Medical.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT07613931: Recruiting Early Phase 1 study, sponsored by Tactile Medical.
NCT07613931 is a Early Phase 1 study that is actively recruiting participants, run by Tactile Medical. The registered enrollment target is 5 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07613931, a Early Phase 1 study, is actively recruiting participants, sponsored by Tactile Medical.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The goal of this pilot study is to learn if a revised method of compression improves lymphatic function compared to the current method of compression. The main questions: • Does the revised method of compression improve lymph movement and lymphatic propulsion?
Primary Outcome
• The distance (cm) that lymph travels from injection sites
Interventions
- DEVICE Advanced pneumatic compression device (APCD)
- DEVICE Advanced pneumatic compression device (APCD) with revised compression programming
- DRUG Indocyanine Green (IC-Green)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-09 |
| Phase | Early Phase 1 |
What NCT07613931 shows while recruiting
NCT07613931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 3 interventions - of which Advanced pneumatic compression device (APCD) is the first listed.
NCT07613931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07613931 about?
NCT07613931 is a clinical study titled "Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment". The goal of this pilot study is to learn if a revised method of compression improves lymphatic function compared to the current method of compression. The main questions: • Does the revised method of compression improve lymph movement and lymphatic propulsion?
What is the current status of trial NCT07613931?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2026-07. Estimated completion is 2026-09.
What interventions are being tested in trial NCT07613931?
The interventions under investigation include: Advanced pneumatic compression device (APCD) (DEVICE), Advanced pneumatic compression device (APCD) with revised compression programming (DEVICE), Indocyanine Green (IC-Green) (DRUG).
Who is sponsoring clinical trial NCT07613931?
This trial is sponsored by Tactile Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07613931's enrollment target sits among peer trials
5 1888th of 2000 higher than 80 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia